The present invention relates to the field of biotechnology and medicine, in particular to a pharmaceutical composition having an antiproliferative activity, and to a method of treating oncological diseases, comprising introducing the aforementioned chimeric peptide to a mammal requiring such treatment. The object of the invention is the development of a preparation that effectively penetrates the target cells and has a high cytostatic and cytotoxic action.